© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Nanobac Pharmaceuticals, Incorporated (NNBP) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 10.75K |
| Aug 17, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 34K |
| Jul 21, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 8K |
| Jun 30, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 113.98K |
| Mar 20, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 10K |
| Mar 18, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1K |
| Mar 10, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1K |
| Mar 03, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 550 |
| Feb 27, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 70K |
| Feb 25, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 10K |
| Jan 12, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 80K |
| Dec 31, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 3.79K |
| Dec 30, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 386K |
| Nov 18, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1K |
| Sep 18, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 15, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 11, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 08, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 04, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 02, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
Nanobac Pharmaceuticals, Incorporated is dedicated to advancing human health through the creation and refinement of products and services designed for the identification and management of calcifying nanoparticles (CNPs). The company's offerings include the production and sale of in vitro diagnostic (IVD) kits, which encompass assays, antibodies, and reagents specifically developed for detecting CNPs. Notably, their diagnostic assays include NANO-CAPTURE and NANO-SERO. Furthermore, Nanobac engages in research and clinical studies focused on various urological diseases—such as chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases—as well as cardiovascular ailments. Established in 1994 and headquartered in Tampa, Florida, the company operated as HealthCentrics Inc. until its name change to Nanobac Pharmaceuticals, Incorporated in December 2002.
| Employees | 1 |
| Beta | -8.83 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Biotechnology |